For research use only. Not for therapeutic Use.
AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects[1].
| Catalog Number | R064847 |
| CAS Number | 1010096-65-7 |
| Synonyms | N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-2-carboxamide |
| Molecular Formula | C17H17N5O |
| Purity | ≥95% |
| InChI | InChI=1S/C17H17N5O/c1-21(2)17(23)22-19-16(18-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3 |
| InChIKey | VBVLSXPOMAONNK-UHFFFAOYSA-N |
| SMILES | CN(C)C(=O)N1N=C(N=N1)CC2=CC=C(C=C2)C3=CC=CC=C3 |
| Reference | [1]. Vinogran Naidoo, et al.Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase – dual targets of the endocannabinoid system to protect against seizure pathology.Neurotherapeutics.2012 Oct;9(4):801-13. |
